TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PACB

Pacific Biosciences of California

Healthcare · Medical Devices

1.40$ +3.0% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Pacific Biosciences of California (PACB): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 6.9 % 23 Q4 23 · 3.6 % 23 Q1 24 · 0.0 % 24 Q2 24 · 9.1 % 24 Q3 24 · 19.1 % 24 Q4 24 · -17.7 % 24 Q1 25 · 21.1 % 25 Q2 25 · 27.8 % 25 Q3 25 · 25.0 % 25 Q4 25 · 7.7 % 25 Q1 26 · 7.7 % 26 Q2 26 · 0.0 % 26

EPS estimate beaten

Full history 29 of 63 quarters (46%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/08/2026 Earnings Call Q1 2026 Open →
  • 02/12/2026 Earnings Call Q4 2025 Open →
  • 11/05/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →
  • 05/08/2025 Earnings Call Q1 2025 Open →
  • 02/13/2025 Earnings Call Q4 2024 Open →
  • 11/07/2024 Earnings Call Q3 2024 Open →
  • 08/07/2024 Earnings Call Q2 2024 Open →
  • 05/09/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/05/2026 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB): Results of Operations and Financial Condition; Cost Associated with Exit or Disposal Activities; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/09/2026 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?